Effect of diabetes drug on brain response to insulin
Part of Hormones & metabolism clinical trials.
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your BMI (body mass index) must be between 18.5 and 24.9 or between 27.5 and 40
- You must not have diabetes (type 1, type 2, or other rare forms)
- You must not have serious heart, brain, or mental health conditions
- You cannot be pregnant, breastfeeding, or planning to become pregnant without using birth control
- You must have no metal implants (like pacemakers or metal screws) that would interfere with MRI scans
- You must not have taken part in another drug or lifestyle study in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if exercise training changes how your brain responds to insulin. You will do ergometer (stationary bike) training, and your brain activity will be measured before and after. It's for people who are not very active now and want to see how exercise affects brain metabolism.
This study looks at how insulin affects blood vessels and the brain in people with obesity and insulin resistance, compared to healthy-weight individuals. It may help explain why obesity raises heart and blood vessel risks.
This study looks at how giving insulin in a way that mimics the body's natural release can affect thinking and memory. It may help understand how insulin relates to brain health.
This study looks at how your brain sends signals to your body, comparing healthy people and those who are overweight. You'll help researchers understand differences in nerve communication.
This study tests whether a single dose of a common antipsychotic medication affects how the brain responds to insulin, which could help explain weight gain and metabolic side effects. Healthy young adults will receive either the antipsychotic or a placebo, then have their brain activity measured with an MRI.
This study tests a new medication to see if it can improve how your body responds to insulin and boost your cells' energy (mitochondrial function). It is for adults with type 1 diabetes who are already on insulin and have good overall health.
Hear when a new Insulin Sensitivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.